Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Finished Goods (2022 - 2025)

TELA Bio has reported Finished Goods over the past 4 years, most recently at $10.9 million for Q4 2025.

  • Quarterly results put Finished Goods at $10.9 million for Q4 2025, down 13.82% from a year ago — trailing twelve months through Dec 2025 was $10.9 million (down 13.82% YoY), and the annual figure for FY2025 was $10.9 million, down 13.82%.
  • Finished Goods for Q4 2025 was $10.9 million at TELA Bio, down from $12.6 million in the prior quarter.
  • Over the last five years, Finished Goods for TELA hit a ceiling of $13.1 million in Q4 2023 and a floor of $10.9 million in Q4 2025.
  • Median Finished Goods over the past 4 years was $12.2 million (2022), compared with a mean of $12.1 million.
  • Biggest five-year swings in Finished Goods: increased 11.11% in 2023 and later dropped 13.82% in 2025.
  • TELA Bio's Finished Goods stood at $11.8 million in 2022, then grew by 11.11% to $13.1 million in 2023, then decreased by 3.49% to $12.6 million in 2024, then fell by 13.82% to $10.9 million in 2025.
  • The last three reported values for Finished Goods were $10.9 million (Q4 2025), $12.6 million (Q4 2024), and $13.1 million (Q4 2023) per Business Quant data.